New Therapy First to Target Type 1 Diabetes Disease Process
A Barbara Davis Center for Diabetes patient became the first person in Colorado to receive a newly approved drug aimed at delaying onset of clinical stage type 1 diabetes. Erik Aeling was the first person in Colorado to receive the newly approved drug. The Aelings also know what a blessing it could be for them and families like theirs to delay the start of type 1 for Erik; in turn delaying the financial strain of diabetes, the number of years Erik will live with this daily challenge, and the possible complications type 1 comes with. Join us as we celebrate this milestone and donate to CDF today!
Read full article here: https://news.cuanschutz.edu/news-stories/new-therapy-first-to-target-type-1-diabetes-disease-process?utm_source=today_newsletter&utm_medium=email&utm_campaign=apr_19_23
